Sveriges Riksbank
Bid date, 2021-03-08 | |
Auction date | 2021-03-08 |
Settlement date | 2021-03-08 |
Maturity Date | 2021-06-07 |
Term | 13 weeks |
Interest rate | The Riksbank´s applicable repo rate |
Bid times | 11.00-11.30 (CET/CEST) on the Bid date |
Confirmation of bids to e-mail | eol@riksbank.se |
Offered volume | Unlimited |
The lowest accepted bid volume | 50 million SEK |
Maximum number of bids | 1 |
Allocation Time | 11.45 (CET/CEST) on the Bid date |
Stockholm, 2021-03-08
Bid date, 2021-03-08 | |
Auction date | 2021-03-08 |
Settlement date | 2021-03-08 |
Maturity Date | 2021-09-06 |
Term | 26 weeks |
Interest rate | The Riksbank´s applicable repo rate |
Bid times | 11.00-11.30 (CET/CEST) on the Bid date |
Confirmation of bids to e-mail | eol@riksbank.se |
Offered volume | Unlimited |
The lowest accepted bid volume | 50 million SEK |
Maximum number of bids | 1 |
Allocation Time | 11.45 (CET/CEST) on the Bid date |
Stockholm, 2021-03-08
This is a translation of the Swedish version published on www.riksbank.se. In the case of any inconsistency between the English translation and the Swedish language version, the Swedish language version shall prevail. Complete terms and conditions can be retrieved at www.riksbank.se.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
TCM Group A/S20.10.2025 07:56:33 CEST | Press release
TCM Group A/S: Major shareholder announcement
TCM Group A/S20.10.2025 07:56:33 CEST | Pressemeddelelse
TCM Group A/S: Storaktionærmeddelelse
Sampo plc20.10.2025 07:30:00 CEST | Press release
Sampo plc’s share buybacks 17 October 2025
F. Hoffmann-La Roche Ltd20.10.2025 07:05:00 CEST | Press release
Roche’s Tecentriq showed significant overall and disease-free survival benefits in bladder cancer with ctDNA-guided treatment
Sanofi Winthrop Industrie20.10.2025 07:00:00 CEST | Press release
Press Release: Sanofi’s high-dose influenza vaccine demonstrates superior protection for older adults against hospitalization vs standard-dose
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom